Eligible participants must meet the following criteria, in addition to other criteria:
There are additional eligibility requirements that the study doctor can explain to you.
Participation in the CAHlibrate Study lasts approximately 11 weeks and consists of four periods:
approximately three weeks
24 hours (takes place approximately seven days prior to the first day of dosing)
approximately five weeks
Throughout the study, your study doctor may perform a number of tests and procedures, including but not limited to: